Euromed Launching a New Extract at SSW17

Date: September 27 – 28, 2017
Location: Las Vegas, Nevada, USA

Our teams from Europe and US were busy at Stand NN123 providing information on the broad list of Euromed extracts, including our newest ABAlife™, an innovative fig fruit extract standardized in abscisic acid (ABA), indicated for blood glucose management, officially launched at SSW.

The development of ABAlife™ is the result of a partnership with BioTherapeutics (BTI) that was announced at SSW. As a part of this deal, BTI has granted an exclusive license to Euromed for patented technology for abscisic acid (ABA).

Dr. Josep Bassaganya-Riera, President and CEO of BTI, gave a presentation at our stand describing the key features of this innovative extract.

September 28, 2017 Uncategorized
Our site uses cookies. By continuing to use our site you are agreeing to our cookies policy. OK